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Background: Prospective studies have shown incidence rates of hypertension in diabetes mellitus to be three
times that of subjects without diabetes mellitus. The reverse also applies, with the incidence of diabetes two to
three times higher in patients with hypertension. Despite this common clinical association, the contribution of each
isolated entity in the development of a neuropathy is still not well understood. The aims of the present study were
to investigate the presence of peripheral neuropathy in spontaneously hypertensive rats (SHR) and SHR with
chronically induced diabetes, using a morphological and morphometric study of the sural nerves.
Methods: Female SHR and normotensive Wistar rats (WR), 8 weeks old, received a single intravenous injection of
streptozotocin (STZ) through the tail vein. Controls from both strains received vehicle. Twelve weeks after the
injection, sural nerves were dissected and prepared for light microscopy. Morphometry of sural nerve fascicles
and myelinated fibers was performed with the aid of computer software.
Results: The sural nerve myelinated fibers were highly affected by experimental diabetes in normotensive rats,
causing mainly the reduction of the fiber size. Hypertensive rats showed characteristics of small fiber neuropathy
and a severe reduction of the number and density or Schwann cells. The association between diabetes and
hypertension caused an increase on the average size of the myelinated fibers, pointing to a small fiber loss,
associated to axonal atrophy.
Conclusions: Our study gives morphological support to the existence of a neuropathy due to hypertension, which is
among one of the most common risk factors for diabetic neuropathy. The association between the two neuropathies
showed to be a complex alteration, involving and including both, large and small fibers neuropathy. Hypertension
caused, indeed, an exacerbation of the alterations already observed in experimental models of diabetic neuropathy.
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It has been pointed out that hypertension is a main risk
factor for stroke and vascular dementia [1]. The important
changes to the cerebrovascular tree caused by hypertension
turn the brain more susceptible to infarcts, microaneurysms
and ischemia [1]. On the peripheral nervous system,* Correspondence: vpsfazan@yahoo.com.br
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unless otherwise stated.alterations in endoneural blood vessels can cause
morphological and morphometric changes in peripheral
nerves [1-4]. Previous results from our laboratory [4]
showed that the sustained high blood pressure in
adult spontaneously hypertensive rats (SHR) affected
the sural nerve myelinated fibers, morphologically and
morphometrically.
Spontaneously hypertensive rats (SHR), first inbred
from Wistar-Kyoto rats (WKY), are considered a good
experimental model of human essential hypertension
[5,6], and it is expected that WKY would be used as the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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protocols. Nevertheless, Wistar rats (WR) have been
recently used as the SHR controls as often as the WKY [7],
mainly because WKY are not readily or easily available.
Sanada et al. [7] showed that sural nerve morphology is
similar between WKY and WR, allowing the use of WR as
the SHR controls in morphological investigations involving
peripheral neuropathies.
Prospective studies have shown incidence rates of
hypertension in diabetes mellitus to be three times that
of subjects without diabetes mellitus. The reverse also
applies, with the incidence of diabetes two to three times
higher in patients with hypertension [8,9]. Tesfave et al.
[10] found an association between the prevalence of
diabetic neuropathy and the presence of cardiovascular
disease, as hypertension. Despite this common clinical
association, the contribution of each isolated entity in the
development of a neuropathy is still not well understood
and few reports deal with the experimental diabetes
associated to hypertension in morphological and/or
morphometric alterations of the peripheral nerves of rats.
We aimed to investigate the possible alterations of
morphological and morphometric parameters of sural
nerves fascicles and myelinated fibers, in adult female
rats, with well-established hypertension. We also compared
the effects on nerve morphology of chronic induced
diabetes associated with hypertension.
Materials and methods
All procedures adhered to “The ARRIVE guidelines:
Animal Research: Reporting In Vivo Experiments, originally
published in PLoS Biology, June 2010” and were approved
by the Institutional Ethics Committee for Animal Research
(CETEA - Comitê de Ética em Experimentacão Animal,
protocol number 030/2006). A conscious effort was done
to minimize the number of animals used.
Experiments were performed on female SHR and
Wistar rats, born and raised in a carefully regulated
environment maintained at 21°C - 23°C, 40% - 70%
relative air humidity, and 12/12 hr light/dark cycle,
receiving tap water and normal rat chow ad libitum,
throughout the experiment. Four experimental groups
were used (N = 6 for each group): 1) Wistar control
(WR) - animals which received only vehicle (citrate
buffer) 12 weeks before the experiments; 2) Wistar
Diabetic (WR + STZ) - rats which received streptozotocin
(STZ) injection 12 weeks before the experiments; 3) SHR
control (SHR) - animals which received only vehicle
(citrate buffer) 12 weeks before the experiments; 4) SHR
Diabetic (SHR + STZ) - rats which received STZ injection
12 weeks before the experiments. Experimental diabetes
was induced in female rats with 8 weeks of age through
STZ (60 mg/kg) intravenous injection as described
previously [11-14]. The vein used for the injections,either of STZ or vehicle was the tail vein. The animals
were considered diabetic when the blood glucose levels
were higher than 350 mg/dl. On the STZ injected animals,
the onset of diabetes occurred rapidly and was identified
by polydipsia and polyuria. Non-fasting blood glucose
(mg/dl) was determined with a glucose analyzer (Beckman
Instruments, Inc., Brea, CA, USA) 3 days after STZ injec-
tion and immediately before the experiments, in blood
droplets collected from an incision at the tip of the tail.
On the final experimental day (12 weeks after injec-
tions), animals were anesthetized with sodic thiopental
(Thionembutal, 40 mg kg, i.p.) and a catheter was
inserted into the femoral artery for measurement of
arterial pressure (AP). Recordings of the systolic (SAP),
diastolic (DAP), mean arterial pressure (MAP) and heart
rate (HR) were performed as described elsewhere
[15,16]. After the recordings, rats were perfused through
the left ventricle first with a 0.05 M phosphate-buffered
saline solution, pH 7.4 and then with a 2.5% glutaraldehyde
solution in 0.1 M cacodylate buffer, pH 7.2. Both right and
left sural nerves, from their origin in the hip (5–7 mm
distal to the greater trochanter) through their distal branch-
ing at the lateral malleolus level, were carefully dissected
without stretching, removed in one piece and placed in the
fixative solution for an additional 12 hour. They were
washed in cacodylate buffer, pH 7.2, and proximal (close to
the origin) and distal (close to terminal branching)
segments (of approximately 3 mm each) were cut and
processed for epoxy resin embedding (EMbed-812®,
Electron Microscopy Sciences, Hatfield, PA, USA) as
described previously [2,7,17,18]. Samples of all four
experimental groups were histologically processed at once
so that they were submitted to absolutely the same experi-
mental conditions throughout the experiments.
Semithin (0.5 μm thick) transverse sections of the
fascicles were stained with 1% toluidine blue and examined
with the aid of an Axiophot II photomicroscope (Carl Zeiss,
Jena, Germany). The images were sent via a digital camera
(TK- 1270, JVC, Victor Company of Japan Ltd, Tokyo,
Japan) to an IBM/PC where they were digitized. The study
of nerve fascicles, myelinated fibers and endoneural space
were performed following the methods developed in our
laboratory [2,7,17-21]. Morphometric data obtained were:
fascicular area and diameter, myelinated fiber number and
density, Schwann cell nuclei number and density, area and
diameter of each myelinated fiber (defined by the axon and
its respective myelin sheath, excluding the Schwann cell
nucleus when present) and respective axon (fiber excluding
the myelin sheath) and myelin sheath area of each fiber
present in the endoneural space and the g ratio (the ratio
between the axon diameter and total fiber diameter - which
indicates the degree of myelination) [22,23]. The percentage
of the total cross-sectional area of the endoneural space
occupied by the blood vessels was calculated, and hereafter
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software used for the morphometry process was the KS
400, Kontron 2.0 (Eching Bei München, Germany).
Morphometric data were tested for normal distribution
by the Kolmogorov-Smirnov normality test followed by the
Levene test for variance equivalence. If data presented a
normal distribution and equivalent variance, comparisons
were made between proximal and distal segments in
the same group by paired Student’s t-test. Otherwise,
comparisons were made by Wilcoxon’s nonparametric
test for paired samples. For comparisons between
right and left segments in the same group, normally
distributed data were tested using the unpaired Student’s
t-test. Alternatively comparisons were made by the
Mann–Whitney non-parametric test. Comparisons between
groups either for physiological or morphometric data were
made by one-way analysis of variance (ANOVA) followed
by Holm-Sidak post hoc test. Comparisons between
histograms were made by one-way analysis of variance
(ANOVA) on Ranks provide that the distributions did not
pass the normality test. For all applied statistical tests, differ-
ences were considered significant when p < 0.05. Data are
presented as mean ± standard error of the mean (SEM).
Results
Body weight, blood glucose level, MAP and HR values
for all experimental groups 12 weeks after the injections
are shown in Table 1. Hyperglycemia observed after
12 weeks of STZ injection reached similar levels in WR
and SHR rats. There was a continuous body weight
gain over time since the injections in animals from all
experimental groups but STZ-injected animals did not
gain as much weight as their respective controls.
All sural nerves included in this study showed good
preservation of structures and general morphological
characteristics of the sural nerve fascicles of WR,
WR + STZ, SHR and SHR + STZ were similar to those
previously described [2,7,17,18]. The comparisons between
segments for all groups showed no endoneural morpho-
logical differences on the same side. Likewise, comparison
between nerves from right and left sides showed no differ-
ences for all groups. However, the comparison betweenTable 1 Body weight, blood glucose level, mean arterial press
injections, from normotensive Wistar rat control group (WR),
group (WR + STZ), spontaneously hypertensive rat group (SH
diabetes group (SHR + STZ)
Body weight (g) Blood gluco
WR 363 ± 8 97 ± 6
WR + STZ 243 ± 25 355 ± 38*#
SHR 193 ± 6* 96 ± 1
SHR + STZ 153 ± 9* 305 ± 35*#
*indicates significant difference compared to Normotensive Wistar rat (WR) group; +
chronic induced diabetes (WR + STZ) group; # indicates significant difference compastrains indicated that the sural nerves from SHR and
SHR + STZ showed a larger number of collapsed blood
vessels and/or vessels with thickening of the wall (Figure 1).
In addition, some myelinated fibers with degenerative signs
were present in both SHR groups. Moreover, in SHR + STZ
group a larger number of myelinated fibers with smaller
caliber and thickening of the myelin sheath could be
observed (Figure 1).
The statistical analysis of the morphometric data, for
fascicles and fibers, did not show intra-group differences,
neither between segments (proximal and distal on the
same side), nor between sides. Thus, morphometric
results will be presented and discussed based on the
comparison between the different experimental groups.
Fascicle morphometric data are shown in Table 2. The
fascicular area of sural nerve in SHR + STZ was signifi-
cantly smaller compared to WR and WR + STZ groups
(p < 0.001). The same observation was made for the
myelinated fiber number, Schwann cell nuclei number,
Schwann cell nuclei density and capillary percentage of
occupancy (p < 0.001). Myelinated fiber number in SHR
group was significantly smaller compared to WR and
WR + STZ groups. On the other hand, SHR + STZ and
SHR groups showed a higher myelinated fiber density
compared to WR and WR + STZ groups (p < 0.001).
Myelinated fiber morphometric data are shown in
Table 3. The control group (WR) showed significantly
higher values of myelinated fiber area and diameter
compared to all other experimental groups (p < 0.001).
Similar results were observed for the myelin sheath area
(p < 0.001) but this parameter was also significantly
higher in WR + STZ group when compared to SHR and
SHR + STZ groups. Myelinated axon area was significantly
smaller in WR+ STZ group when compared to SHR and
SHR + STZ group. There was a tendency towards larger
myelinated axon diameter on both SHR groups, and this
was reflected on the g ratio values, being the SHR g ratio
average larger than both WR groups.
Distributions of myelinated fiber and axon diameters
and g ratio values are shown in Figure 2. Myelinated
fiber diameters ranged from 1.0 to 11.0 μm in all four
groups, with a bimodal distribution. For the SHR groups,ure (MAP) and heart rate (HR) data, at 12 weeks after
normotensive Wistar rat with chronic induced diabetes
R), spontaneously hypertensive rat with chronic induced
se (mg/dl) MAP (mmHg) HR (bpm)
119 ± 13 312 ± 46
116 ± 6# 269 ± 31
180 ± 7 310 ± 12
181 ± 11 373 ± 12+
indicates significant difference compared to Normotensive Wistar rat with
red to Spontaneously hypertensive rat (SHR) group.
Figure 1 Representative semithin cross section of the sural nerve from normotensive Wistar rat. (A), normotensive Wistar rat with
chronically induced diabetes (B), Spontaneously hypertensive rat (C) and Spontaneously hypertensive rat with chronically induced diabetes
(D), showing typical endoneural structures. Large (M) and small myelinated fibers are present in the endoneural space. Note the presence of
normal endoneural vessels (V) in A and B while in C and D, the vessels show thickening of the walls and reduced lumen. In D, arrows indicate
axons with atrophy and arrowheads indicate myelinated fibers with severe myelin disruption. Toluidine blue stained. Bar = 10 μm.
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WR presented peaks at 3.5 μm. For the large myelinated
fibers, all four groups presented peaks at 6.5 μm but the
WR + STZ showed a larger percentage of these fibers
while the SHR + STZ showed a smaller percentage of
these fibers compared to all other groups. No differences
between the large fibers peak was observed between WR
and SHR. The myelinated fiber axon diameters ranged
from 0.5 to 6.5 μm in all groups distributed in an
unimodal shape, with peak at 2.5 μm in all groups, with
no differences between groups.
For the g ratio distributions, the range was between
0.2 and 1.0 for all groups but with significant differences
on the peaks between groups. While WR presented peak
at 0.5, WR + STZ showed a plateau between 0.5 and 0.6.Table 2 Average morphometric data of sural nerves fascicles
rat control group (WR), normotensive Wistar rat chronically i
hypertensive rat group (SHR), spontaneously hypertensive ra
WR
Fascicular area (μm2) 76963 ± 436
Fascicular diameter (μm) 202 ± 24
Myelinated fiber number 1079 ± 82
Myelinated fiber density (number of fibers/μm2) 13994 ± 601
Schwann cell nucleus number 60 ± 5
Schwann cell nucleus density (number of nucleus/μm2) 789 ± 60
Capillary occupancy (%) 0.90 ± 0.18
*indicates significant difference compared to Normotensive Wistar rat (WR) group; +
chronic induced diabetes (WR + STZ) group; # indicates significant difference compaFor both SHR groups, there was a plateau between 0.6
and 0.7 with higher percentage of fibers with these
values on SHR groups, compared to the SHR + STZ.
Discussion
For a long time, our laboratory has been dedicated to
investigate abnormalities in the morphology and morph-
ometry of peripheral nerves due to hypertension
[2,3,7,24-27], pointing to the description of a so called
“hypertensive neuropathy”. In fact, it was recently
described that non-diabetic patients with chronic un-
treated hypertension may develop impairment of nerve
function [28]. The positive correlation between hyper-
tension and diabetes described in humans drove us to
investigate this association under controlled experimentalfrom the four experimental groups: normotensive Wistar
nduced diabetes group (WR + STZ), spontaneously
t chronically induced diabetes group (SHR + STZ)
WR + STZ SHR SHR + STZ
1 64739 ± 3732 50018 ± 2047 42670 ± 2345*+
169 ± 17 153 ± 10 156 ± 11
1039 ± 50 849 ± 28*+ 767 ± 28*+
16894 ± 1113 17206 ± 391*+ 18471 ± 684*+
66 ± 4 51 ± 2 28 ± 2*+#
1094 ± 103 1055 ± 60*+ 670 ± 77+#
0.91 ± 0.17 0.43 ± 0.08 0.27 ± 0.06*+
indicates significant difference compared to Normotensive Wistar rat with
red to Spontaneously hypertensive rat (SHR) group.
Table 3 Average morphometric data of sural nerves myelinated fibers from the four experimental groups: normotensive
Wistar rat control group (WR), normotensive Wistar rat chronically induced diabetes group (WR + STZ), spontaneously
hypertensive rat group (SHR), spontaneously hypertensive rat chronically induced diabetes group (SHR + STZ)
WR WR + STZ SHR SHR + STZ
Myelinated fiber area (μm2) 33.46 ± 0.74 29.00 ± 0.89* 25.65 ± 0.62* 27.47 ± 1.47*
Myelinated fiber diameter (μm) 5.48 ± 0.07 5.10 ± 0.08* 4.78 ± 0.07* 4.81 ± 0.10*
Myelin sheath area (μm2) 25.69 ± 0.55 21.56 ± 0.80* 16.49 ± 0.40*+ 17.90 ± 0.75*+
Myelinated axon area (μm2) 8.19 ± 0.25 7.38 ± 0.26 9.16 ± 0.25+ 9.56 ± 0.54+
Myelinated axon diameter (μm) 2.67 ± 0.05 2.65 ± 0.05 2.86 ± 0.04 2.80 ± 0.09
g ratio 0.49 ± 0.01 0.53 ± 0.01 0.61 ± 0.01*+ 0.60 ± 0.01
*indicates significant difference compared to Normotensive Wistar rat (WR) group; + indicates significant difference compared to Normotensive Wistar rat with
chronic induced diabetes (WR + STZ) group.
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study showed that the sural nerve myelinated fibers were
highly affected by experimental diabetes, causing mainly
the reduction of the fiber size. But the most striking result
from this work is that the association between diabetes
and hypertension caused an increase on the average size
of the myelinated fibers, pointing to a small fiber loss, as-
sociated to axonal atrophy.
Abnormalities reported in human diabetic neuropathy
include axonal degeneration, primary demyelination
resulting from Schwann cell dysfunction, secondary
segmental demyelination related to impairment of the
axonal control of myelination, remyelination, proliferation
of Schwann cells, atrophy of denervated bands of
Schwann cells, onion-bulb formations and hypertrophy of
the basal lamina [29,30]. Animal models of diabetes still
do not reproduce all morphological alterations present in
human nerves, but offer the possibility of investigating
the disease under controlled risk factors environment,
including the association with co-morbidities or risk factor
for the disease.
De Visser et al. [31] studied the association of hyperten-
sion and type II diabetes in adult rats, comparing the
Zucker Diabetic Fatty Rat (ZDF - a well stablished model of
type II diabetes) and a genetic hybrid between the ZDF and
the Spontaneously Hypertensive Heart Failure rat. The
main finding for the diabetic rats was the presence of
thinned myelin with a mild additive effect of hypertension
that appeared only after 6 months of diabetes. Our results
for the diabetic rats are somewhat similar to those from De
Visser et al. [31] since we also demonstrated a small myelin
area that was reflected on the total fiber size (smaller on
WR+ STZ compared to WR). On the other hand, on SHR
animals, when compared to SHR+ STZ, there was a
tendency for increase in the average myelin area, associated
with the increase in fiber size, suggestive of small myelin-
ated fiber loss. In addition to these morphometric findings,
SHR + STZ animals showed a great number of myelinated
fibers with severe disruptions of the myelin sheath,
particularly in large myelinated fibers (Figure 1).Impairment of the motor conduction velocity in
nerves from diabetic animals was described as related to
large myelinated fibers dysfunction. Yamaguchi et al.
[32] investigated the tail motor nerve conduction
velocity in male Spontaneously Diabetic Torii-Leprfa rats
(SDT Fatty). They demonstrated a reduction by 18% in
the motor nerve conduction velocity in 24 weeks old
SDT Fatty rats, compared to controls. In our study, the
conduction velocity was not investigated because
alterations in conduction velocity usually occur after a
longer period then the experimental time we used
(20 weeks of age, 12 weeks after diabetes induction).
In our experimental model, because diabetes is severe
(blood sugar levels sustained above 300 mg/dl without
treatment), the animals do not survive under ethical
conditions much longer than 12 weeks. Nevertheless,
because larger fiber impairment is readily detectable in
nerve conduction studies, and our study demonstrated
that smaller fibers were more affected, we believe that the
conduction studies in our experimental model would not
add much.
It has been suggested that hyperglycemia is one factor
for increasing Schwann cell metabolic stress. In fact, we
recently have shown alterations of the Schwann cells
mitochondria in nerves from acute STZ-diabetic rats [33].
The association between hypertension and hyperglycemia
has also been suggested as a stress for the Schwann cells
[9,31,34]. Our results showed that hypertension (without
diabetes) significantly decreased the number and density
of Schwann cells in the sural nerve compared to normo-
tensive animals and, in the SHR + STZ, this number was
reduced compared to SHR. The reduction in number of
Schwann cells might be responsible, at least in part, for
the severe myelin alterations we observed in SHR,
with or without diabetes. Since the Schwann cells are
the myelinating cells, an ideal relation or ratio between
the number of the Schwann cells, the axon size and the
myelin thickness is expected. The disruption of this ideal
relation, like the reduction in the Schwann cells number
can certainly cause myelin morphology alterations similar
Figure 2 Size distribution histograms of myelinated fibers. (A),
respective axons (B) and g ratio (C) of sural nerve in normotensive Wistar
rat (WR), normotensive Wistar rat with chronically induced diabetes
(WR + STZ), Spontaneously hypertensive rat (SHR) and Spontaneously
hypertensive rat with chronically induced diabetes (SHR + STZ). WR+ STZ
showed a higher peak at larger fibers while the SHR+ STZ showed a
lower peak of these fibers compared to all other groups. Myelinated
axons presented a slight shift to smaller size in SHR+ STZ group
compared to all others. The g ratio distributions in both SHR groups are
shifted to the right compared to normotensive groups.
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diabetic nerves was ascribed not only to hyperglycemia,
but also to abnormal fatty acid metabolism, ischemic
hypoxia and oxidative stress. The present study did not
aim to investigate nerve metabolism but it has been shown
that pharmacological interventions such as treatment with
free radical scavenger can be effective in the prevention of
the experimental diabetic neuropathy [35-37].
Thickening of the Schwann cell basement membrane
is one of the alterations in diabetes, shown by ultrastru-
cutral investigations of peripheral nerves [14,33,38]. In
our material it is evident that unmyelinated fibers are
easily visible in diabetic animals (normotensive and
hypertensive) compared to controls and also in SHR
(Figure 1). An ultrastrucutral study of this material will
help us to clarify this issue.
A reduction of myelinated nerve fiber size is the most
characteristic and reproducible abnormality of peripheral
nerve in experimentally induced diabetic rats [19,39-47].
This reduction is claimed to be due to a reduction in
axon size caused by metabolic alterations in the axons
[39,41,42,45,46], retarded growth rate [40,44], or increased
hyperosmolarity [43]. More recently, the alterations of the
endoneural microvasculature is also pointed out as a
factor for the axon size reduction [12,13].
Our results of myelinated fiber alteration in hypertensive
rats are very likely to be explained by the morphological
changes in endoneural microvessels associated with hyper-
tension, as described before [2,4]. Besides the larger num-
ber of collapsed blood vessels (with thickening of the walls
and absence of lumen) and/or vessels with thick walls in
SHR and SHR + STZ, a smaller fascicular area occupied by
the capillary was statistically significant in these animals.
Gregory et al. [9] observed reduction of endoneural blood
vessels in SHR, associated to a decrease in sciatic nerve
blood flow. Associated to these findings, they also showed
reduced axonal diameter in SHR and diabetic SHR in the
absence of changes to other structural parameters [9]. In
line with our results, they affirmed that large fiber
neuropathy in SHR resembled that of STZ-diabetic
rats, but includes axons with thin myelin, suggestive
of segmental demyelination/remyelination. The large
fiber neuropathy present in our results for SHR can
be identified by the reduced percentage of the large
fibers peak on the distribution histograms (Figure 2),
which is accentuated by the association between
hypertension and diabetes. Adding to their results, we
also show the small fiber neuropathy in SHR, through
the myelinated fiber distribution shift to the right,
also blunted by the association between hypertension
and diabetes (Figure 2). The small fiber neuropathy in
hypertension, similar to the one described in this study,
was previously characterized in SHR though results
obtained in our laboratory [2], by the decrease in number
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fiber average size and the shift in fiber distribution
histograms.
Experimental models of arterial infarct suggested
that small nerve fibers are more vulnerable to ische-
mia than the large nerve fibers [48,49]. Thus, small
fiber neuropathy in SHR can be associated to the
damage of endoneural vessels [2,4]. In favor of the
small fibers loss, an altered g ratio was also observed
in the current study (Table 3 and Figure 2). The shift
to the right observed in the g ratio distributions in
SHR (diabetic and non-diabetic) could be suggestive
of demyelination, as pointed out by Gregory et al.
[9]. On the other hand, it is also described that
larger fibers present larger g ratios compared to
smaller fibers [50,51]. If the smaller fibers were lost,
larger fibers will shift the g ratio distribution to the
larger values.
The data presented here resulted from a comparison
between SHR and Wistar rats, with or without experi-
mentally induced diabetes. Spontaneously hypertensive
rats (SHR) were first inbred from their normotensive
counterparts, the Wistar-Kyoto rats (WKY). Thus, it
would be expected for WKY to be used as the
normotensive controls of SHR in diverse experimental
protocols [7]. Nevertheless, Wistar rats (WR) have
been recently used as the SHR controls as often as
the WKY [52,53]. Peripheral nerve function is significantly
affected by maturation and aging but rats described as
adults have weights that vary in a range of about 180 g to
1000 g or more [17,54]. In the present study, animals with
absolutely the same age but significantly different
body weight presented similar fascicular area and
diameter of the sural nerves. This indicates that the
nerves developed in a similar way and the stress due
to hypertension did not impact the overall SHR develop-
ment. Actually, SHR are described as presenting smaller
body weight compared to age matched WKY [9] as well as
to Wistar rats [7].Conclusion
Our study gives morphological support to the existence
of a neuropathy due to hypertension, which is among
one of the most common risk factors for diabetic
neuropathy. The association between the two neurop-
athies showed to be a complex alteration, involving
and including both, large and small fibers neuropathy.
Hypertension caused, indeed, an exacerbation of the
alterations already observed in experimental models
of diabetic neuropathy.Competing interests
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